Furthermore, hsa_circ_0002130 could increase the expression of lactate dehydrogenase A, hexokinase 2, and glucose transporter 1 in osimertinib-resistant NSCLC cells by specifically inhibiting miR-498. This evidence concerns the gene HK2 and non-small cell lung carcinoma.